The feasibility of dendritic cells (DC) for cancer immunotherapy after transfection by
electroporation with mRNA encoding the human carcinoembryonic antigen (CEA) was …

The application of dendritic cells (DC) to the active immunotherapy of cancer currently relies
on the generation of potent DC capable of presenting tumor antigens such as …

Carcinoembryonic antigen (CEA), which is expressed in several cancer types, is a potential
target for specific immunotherapy. In this study, the feasibility of using dendrite cells (DCs) …

Carcinoembryonic antigen (CEA) is over-expressed on various human cancer cells and has
been the target of immunotherapies using dendritic cells (DCs) pulsed with CEA-specific …

The human carcinoembryonic antigen (CEA), which is expressed in several cancer types is
a potential target for antigen-specific immunotherapy. In this study, we show that dendritic …

Immunizations with dendritic cells (DC) transfected with RNA encoding tumor antigens
induce potent tumor antigen-specific immune responses in vitro and in murine models. We …

Antigen specific cytotoxic T lymphocytes (CTL) are being studied for their potential
immunotherapeutic benefit in the treatment of cancer. Carcinoembryonic antigen (CEA) is an …

This study was designed to determine whether the vaccination of genetically modified
dendritic cells (DCs) simultaneously expressing carcinoembryonic antigen (CEA) …

Identification of relevant targets for cancer therapy is a major goal in cancer research. In this
field, the identification of tumor antigens has opened the possibility of inducing specific anti …

Abstract Background Dendritic cells (DCs) are the professional antigen-presenting cells of
the immune system. As such they are currently used in clinical vaccination protocols in …